Skip to content
20-F

Annual Report (Foreign)

Addex Therapeutics Ltd. ADXN

0001104659-26-062447

← back to feed
Filed
May 15, 2026 12:00 AM ET
Period of report
—

On SEC.gov

Filing index ↗

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Dec 31, 2025 147.83M sh